10x Genomics, Inc.

Historical 13F Holders

Symbol
TXG
CUSIP
88025U109
All holders as of
Q2 2026
Type
Equity
Class
CL A COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 88025U109 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.6% 3/6/2026
Event 2/27/2026
Price T Rowe Associates Inc /MD/ 13G 11.7% 9/8/2026
Event 8/31/2026
BlackRock, Inc. 13G/A 7.6% 7/16/2025
Event 6/30/2025
Vanguard Portfolio Management LLC 13G 5.9% 4/28/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.2% 4/29/2026
Event 3/31/2026
ARK Investment Management LLC 13G/A
5.2% 10/7/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Sumitomo Mitsui Trust Group, Inc. 13G/A
4.7% 10/27/2025
Event 9/30/2025
Amova Asset Management Americas, Inc. 13G/A 4.7% 11/13/2025
Event 9/30/2025
Millennium Management LLC 13G/A
2.7% 8/12/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/25/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 30 343 k $28.5 M
2026 Q2 406 133 M $5.05 B
2026 Q1 343 125 M $2.66 B
2025 Q4 337 124 M $2.02 B
2025 Q3 332 124 M $1.44 B
2025 Q2 307 124 M $1.43 B
2025 Q1 288 114 M $997 M
2024 Q4 287 105 M $1.51 B
2024 Q3 278 105 M $2.37 B
2024 Q2 276 111 M $2.16 B
2024 Q1 308 114 M $4.28 B
2023 Q4 294 102 M $5.73 B
2023 Q3 275 91.7 M $3.78 B
2023 Q2 292 90.4 M $5.05 B
2023 Q1 273 91.2 M $5.09 B
2022 Q4 292 89.0 M $3.25 B
2022 Q3 245 86.1 M $2.45 B
2022 Q2 264 86.1 M $3.91 B
2022 Q1 337 82.8 M $6.30 B
2021 Q4 386 80.0 M $11.9 B
2021 Q3 344 78.8 M $11.5 B
2021 Q2 368 78.0 M $15.3 B
2021 Q1 342 70.6 M $12.8 B
2020 Q4 331 66.6 M $9.43 B
2020 Q3 233 69.1 M $8.55 B
2020 Q2 161 61.0 M $5.45 B
2020 Q1 115 39.3 M $2.45 B
2019 Q4 93 30.9 M $2.36 B
2019 Q3 94 22.4 M $1.13 B